Rocket Pharmaceuticals
RCKT
RCKT
146 hedge funds and large institutions have $1.85B invested in Rocket Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 55 increasing their positions, 49 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
32% less capital invested
Capital invested by funds: $2.74B → $1.85B (-$888M)
Holders
146
Holding in Top 10
4
Calls
$3.68M
Puts
–
Top Buyers
1 | +$44.4M | |
2 | +$24.1M | |
3 | +$17.3M | |
4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$16M |
5 |
Citadel Advisors
Miami,
Florida
|
+$15M |
Top Sellers
1 | -$39.8M | |
2 | -$26.1M | |
3 | -$15.5M | |
4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$14M |
5 |
PA
Perceptive Advisors
New York
|
-$13.2M |